Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: KEGG:D02548 (
Giardiasis
)
236
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Giardiasis
is the most common small intestinal protozoal infection and is found worldwide. The mechanisms by which Giardia duodenalis (= G. lamblia) produces chronic diarrhoea and malabsorption have still not been clearly defined. Many infections are associated with mild to moderate mucosal damage which, in animal models of infection, have functional correlates. Possible mechanisms include direct physical injury, release of parasite products such as proteinases or lectin, and mucosal inflammation associated with T cell activation and cytokine release. Other possible mechanisms of malabsorption include associated bacterial overgrowth and bile
salt
deconjugation, bile
salt
uptake by the parasite with depletion of intraluminal bile salts, and inhibition of pancreatic hydrolytic enzymes. Thus, there is no single mechanism to explain the diarrhoea and malabsorption caused by Giardia, which currently should be regarded as a multifactorial process.
...
PMID:Diarrhoeal disease: current concepts and future challenges. Pathogenesis of giardiasis. 810 43
Giardiasis
, currently considered a neglected disease, is caused by the intestinal protozoan parasite
Giardia duodenalis
and is widely spread in human as well as domestic and wild animals. The lack of appropriate medications and the spread of resistant parasite strains urgently call for the development of novel therapeutic strategies. Host microbiota or certain probiotic strains have the capacity to provide some protection against giardiasis. By combining biological and biochemical approaches, we have been able to decipher a molecular mechanism used by the probiotic strain
Lactobacillus johnsonii
La1 to prevent
Giardia
growth
in vitro
. We provide evidence that the supernatant of this strain contains active principle(s) not directly toxic to
Giardia
but able to convert non-toxic components of bile into components highly toxic to
Giardia
. By using bile acid profiling, these components were identified as deconjugated bile-salts. A bacterial bile-
salt
-hydrolase of commercial origin was able to mimic the properties of the supernatant. Mass spectrometric analysis of the bacterial supernatant identified two of the three bile-
salt
-hydrolases encoded in the genome of this probiotic strain. These observations document a possible mechanism by which
L. johnsonii
La1, by secreting, or releasing BSH-like activity(ies) in the vicinity of replicating
Giardia
in an environment where bile is present and abundant, can fight this parasite. This discovery has both fundamental and applied outcomes to fight giardiasis, based on local delivery of deconjugated bile salts, enzyme deconjugation of bile components, or natural or recombinant probiotic strains that secrete or release such deconjugating activities in a compartment where both bile salts and
Giardia
are present.
...
PMID:Deconjugated Bile Salts Produced by Extracellular Bile-Salt Hydrolase-Like Activities from the Probiotic
Lactobacillus johnsonii
La1 Inhibit
Giardia duodenalis In vitro
Growth. 2772
Giardia duodenalis
is a protozoan parasite responsible for giardiasis, a disease characterized by intestinal malabsorption, diarrhea and abdominal pain in a large number of mammal species.
Giardiasis
is one of the most common intestinal parasitic diseases in the world and thus a high veterinary, and public health concern. It is well-established that some probiotic bacteria may confer protection against this parasite
in vitro
and
in vivo
and we recently documented the implication of bile-
salt
hydrolase (BSH)-like activities from strain La1 of
Lactobacillus johnsonii
as mediators of these effects
in vitro
. We showed that these activities were able to generate deconjugated bile salts that were toxic to the parasite. In the present study, a wide collection of lactobacilli strains from different ecological origins was screened to assay their anti-giardial effects. Our results revealed that the anti-parasitic effects of some of the strains tested were well-correlated with the expression of BSH-like activities. The two most active strains
in vitro
, La1 and
Lactobacillus gasseri
CNCM I-4884, were then tested for their capacity to influence
G. duodenalis
infection in a suckling mice model. Strikingly, only
L. gasseri
CNCM I-4884 strain was able to significantly antagonize parasite growth with a dramatic reduction of the trophozoites load in the small intestine. Moreover, this strain also significantly reduced the fecal excretion of
Giardia
cysts after 5 days of treatment, which could contribute to blocking the transmission of the parasite, in contrast of La1 where no effect was observed. This study represents a step toward the development of new prophylactic strategies to combat
G. duodenalis
infection in both humans and animals.
...
PMID:Bile Salt Hydrolase Activities: A Novel Target to Screen Anti-
Giardia
Lactobacilli? 2947 3